HIGHLIGHTS
- who: Cecilia Livermore from the Pharmacy Department, South London and Maudsley NHS Foundation Trust, Denmark Hill, London , AZ, UK have published the research: A retrospective case notes review of the effectiveness and tolerability of metoclopramide in the treatment of clozapine-induced hypersalivation (CIH), in the Journal: (JOURNAL)
- what: Adverse effects Treatment continuation All patients in this study had trialled at least one other medication for CIH prior to using metoclopramide. The results of this study showed that 6 out of 14 patients (43%) continued treatment with metoclopramide for CIH with a mean duration of 27 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.